Drivers of biodiagnostic development

714 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Inorganic Nanoparticles in Cancer Therapy (2010, neutral): “revolutionize the health care system by fighting deadly diseases in more efficient ways (1).”
Phenomics: the next challenge (2010, background): “Given the magnitude of the phenomic challenge and considering the demands of multi-scale modelling, it is likely that we will need to foster entirely new measurement technologies based, for example, on nanodevice”
Enzyme-responsive nanoparticles for drug release and diagnostics. (2012, background): “For example, nanoparticle-based sensors can detect biomolecules of clinical interest with extreme sensitivity, and the development of these diagnostic tools is crucial for the early detection of diseases such as cancer [6, 7].”
Single-Molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations (2010, background): “Current immunoassays typically measure proteins at concentrations above 10 −12”